| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4849327
Max Phase: Preclinical
Molecular Formula: C47H47FN8O5
Molecular Weight: 822.94
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C=C(C)C(=O)N(CC)c1cc(-c2ccc(N3CCN(C(=O)c4cc(Cc5n[nH]c(=O)c6ccccc56)ccc4F)CC3)nc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C
Standard InChI: InChI=1S/C47H47FN8O5/c1-7-56(46(60)27(2)3)41-24-33(23-36(30(41)6)43(57)50-26-38-28(4)20-29(5)51-44(38)58)32-13-15-42(49-25-32)54-16-18-55(19-17-54)47(61)37-21-31(12-14-39(37)48)22-40-34-10-8-9-11-35(34)45(59)53-52-40/h8-15,20-21,23-25H,2,7,16-19,22,26H2,1,3-6H3,(H,50,57)(H,51,58)(H,53,59)
Standard InChI Key: LPDOHGNBHJLAJC-UHFFFAOYSA-N
Associated Targets(Human)
MDA-MB-231 (73002 Activities)
MDA-MB-468 (9477 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF7 (126967 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
MCF-10A (2462 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
PRAP1 Tchem Proline-rich acidic protein 1 (6 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
EZH2 Tclin Histone-lysine N-methyltransferase EZH2 (2012 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 822.94 | Molecular Weight (Monoisotopic): 822.3653 | AlogP: 6.15 | #Rotatable Bonds: 11 |
| Polar Surface Area: 164.46 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
| #RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
| CX Acidic pKa: 9.95 | CX Basic pKa: 6.91 | CX LogP: 5.17 | CX LogD: 5.15 |
| Aromatic Rings: 6 | Heavy Atoms: 61 | QED Weighted: 0.13 | Np Likeness Score: -1.58 |
References
| 1. Wang C, Qu L, Li S, Yin F, Ji L, Peng W, Luo H, Lu D, Liu X, Chen X, Kong L, Wang X.. (2021) Discovery of First-in-Class Dual PARP and EZH2 Inhibitors for Triple-Negative Breast Cancer with Wild-Type BRCA., 64 (17.0): [PMID:34455779] [10.1021/acs.jmedchem.1c00567] |
Source
Source(1):